Cited by 225Treatment of Major DepressionDiabetes Treatment and ManagementMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus

Guo, Min, Mi, Jia, Jiang, Qiu‐Ming, Xu, Jin‐Mei, Tang, Ying‐Ying, Tian, Geng, Wang, Bin·2014·Clinical and Experimental Pharmacology and Physiology

DOI 10.1111/1440-1681.12265

Open this paper in CoChat — free account

Abstract

Summary: Diabetes mellitus and depressive disorders are both common chronic diseases that increase functional disability and social burden. Cognitive impairment is a potentially debilitating feature of depression. Previous evidence indicates that the antidiabetic drug metformin could be suitable for diabetic patients with cognitive impairment. However, there is no direct evidence from clinical studies that metformin treatment improves cognitive function in diabetic patients suffering from depression. In the present study, 58 participants diagnosed with depression and type 2 diabetes mellitus ( T 2 DM ) were recruited and divided into two groups, one treated with metformin and the other treated with placebo for 24 weeks. Cognitive function, depressive behaviour and diabetes improvement were evaluated. Chronic treatment with metformin for 24 weeks improved cognitive performance, as assessed by the W echsler M emory S cale– R evised, in depressed patients with T 2 DM . In addition, metformin significantly improved depressive performance and changed the glucose metabolism in depressed patients with diabetes. Depressive symptoms were negatively correlated with cognitive performance in metformin‐treated participants. Furthermore, associations were observed between the parameters of blood glucose metabolism and the depression phenotype. These findings suggest that chronic treatment with metformin has antidepressant behavioural effects and that improved cognitive function is involved in the therapeutic outcome of metformin. The results of the present study also raise the possibility that supplementary administration of antidiabetic medications may enhance the recovery of depression, comorbid with T 2 DM , through improvements in cognitive performance.

Integrity signals

Registry

Crossref · 10.1111/1440-1681.12265

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Association of depression and diabetes complications: a meta-analysis
de Groot, M., Anderson, R., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00015 · Cited by 1,799
Cognitive endophenotypes of bipolar disorder: A meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives
Bora, E., Yücel, M., & Pantelis, C. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.009 · Cited by 1,058
Mechanism by which metformin reduces glucose production in type 2 diabetes.
Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V, Chandramouli, V, Inzucchi, S. E., Schumann, W. C., Petersen, K. F., Landau, B. R., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2063 · Cited by 1,052
Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment
Warner‐Schmidt, J. L., & Duman, R. S. (2006) · Hippocampus · doi:10.1002/hipo.20156 · Cited by 787
The Health and Productivity Cost Burden of the “Top 10” Physical and Mental Health Conditions Affecting Six Large U.S. Employers in 1999
Goetzel, R. Z., Hawkins, K., Ozminkowski, R. J., & Wang, S. S. (2003) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-200301000-00007 · Cited by 694
The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior
Schmidt, H. D., & Duman, R. S. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee2aa8 · Cited by 662
Depression and Risk for Onset of Type II Diabetes: A prospective population-based study
Eaton, W. W., Armenian, H. K., Gallo, J. J., Pratt, L., & Ford, D. E. (1996) · Diabetes Care · doi:10.2337/diacare.19.10.1097 · Cited by 611
The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults.
Strine, T. W., Mokdad, A. H., Dube, S. R., Balluz, L. S., Gonzalez, O., Berry, J. T., Manderscheid, R., & Kroenke, K. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.12.008 · Cited by 577

Show all 46 references

Research works printed but not linked: 2

American Psychiatric Association, 2000, Diagnostic and Statistical Manual of Mental Disorders–Fourth Edition
Wechsler D, 1987, Wechsler Memory Scale‐Revised Manual

Sorted by citations

The burden and risks of emerging complications of diabetes mellitus
Tomic, D., Shaw, J. E., & Magliano, D. J. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00690-7 · Cited by 1,377
Metformin as a tool to target aging
Barzilai, N., Crandall, J. P., Kritchevsky, S. B., & Espeland, M. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.011 · Cited by 1,096
Metformin and Its Benefits for Various Diseases
Lv, Z., & Guo, Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00191 · Cited by 563
Metformin: a review of its potential indications
Wang, Y., He, S., Feng, X., Cheng, J. Q., Luo, Y.-T., Tian, L., & Huang, Q. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s141675 · Cited by 330
Metformin Use Associated With Reduced Risk of Dementia in Patients With Diabetes: A Systematic Review and Meta-Analysis
Campbell, J. M., Stephenson, M. D., de Courten, B., Chapman, I., Bellman, S. M., & Aromataris, E. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180263 · Cited by 292
A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan
Mohammed, I., Hollenberg, M. D., Ding, H., & Triggle, C. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.718942 · Cited by 278
Metformin: Is it a drug for all reasons and diseases?
Triggle, C. R., Mohammed, I., Bshesh, K., Marei, I., Ye, K., Ding, H., MacDonald, R. S., Hollenberg, M. D., & Hill, M. A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155223 · Cited by 300
Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia
Sastre, A. A., Vernooij, R. W. M., Harmand, M. G., & Martínez, G. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003804.pub2 · Cited by 283
Metformin – a Future Therapy for Neurodegenerative Diseases
Markowicz-Piasecka, M., Sikora, J., Szydłowska, A., Skupień, A., Mikiciuk‐Olasik, E., & Huttunen, K. M. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2199-y · Cited by 266
Cognitive remission: a novel objective for the treatment of major depression?
Bortolato, B., Miskowiak, K. W., Köhler, C. A., Maes, M., Fernandes, B. S., Berk, M., & Carvalho, A. F. (2016) · BMC Medicine · doi:10.1186/s12916-016-0560-3 · Cited by 252
Type 2 Diabetes Mellitus and Alzheimer’s Disease: Role of Insulin Signalling and Therapeutic Implications
Tumminia, A., Vinciguerra, F., Parisi, M., & Frittitta, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113306 · Cited by 263
Nutritional Aspects of Depression
Lang, U. E., Beglinger, C., Schweinfurth, N., Walter, M., & Borgwardt, S. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430229 · Cited by 255
Diabetes and Mental Health
Robinson, D. J., Coons, M., Haensel, H., Vallis, M., & Yale, J.-F. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.031 · Cited by 209
Should metformin remain the first-line therapy for treatment of type 2 diabetes?
Baker, C., Retzik-Stahr, C., Singh, V., Plomondon, R., Anderson, V., & Rasouli, N. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820980225 · Cited by 204
Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review
Bortolato, B., Carvalho, A., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203823 · Cited by 181
Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes
Silva, N. M. L. E., Lam, M. P., Soares, C. N., Munoz, D. P., Milev, R. V., & Felice, F. G. D. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00057 · Cited by 178
Metformin ameliorates stress-induced depression-like behaviors via enhancing the expression of BDNF by activating AMPK/CREB-mediated histone acetylation
Fang, W., Zhang, J., Hong, L., Huang, W., Dai, X., Ye, Q., & Chen, X. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.09.013 · Cited by 159
Metformin and ageing: improving ageing outcomes beyond glycaemic control
Valencia, W. M., Palacio, A., Tamariz, L., & Florez, H. (2017) · Diabetologia · doi:10.1007/s00125-017-4349-5 · Cited by 142
Differential effects of metformin on age related comorbidities in older men with type 2 diabetes
Wang, C.-P., Lorenzo, C., Habib, S. L., Jo, B., & Espinoza, S. E. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.013 · Cited by 134
Treatment for comorbid depressive disorder or subthreshold depression in diabetes mellitus: systematic review and meta‐analysis
van der Feltz‐Cornelis, C., Allen, S. F., Holt, R. I. G., Roberts, R., Nouwen, A., & Sartorius, N. (2021) · Brain and Behavior · doi:10.1002/brb3.1981 · Cited by 130
The Bidirectional Relationship between Diabetes and Depression: A Literature Review
Alzoubi, A., Abunaser, R., Khassawneh, A., Alfaqih, M. A., Khasawneh, A. G., & Abdo, N. M. (2018) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2018.39.3.137 · Cited by 130
The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth
Amin, S., Lux, A. L., & O'Callaghan, F. J. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13780 · Cited by 128
Protective role of metformin against methamphetamine induced anxiety, depression, cognition impairment and neurodegeneration in rat: The role of CREB/BDNF and Akt/GSK3 signaling pathways
Keshavarzi, S., Kermanshahi, S., Karami, L., Motaghinejad, M., Motevalian, M., & Sadr, S. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.02.004 · Cited by 120
ADULT NEUROGENESIS IN HUMANS: A Review of Basic Concepts, History, Current Research, and Clinical Implications.
Kumar, A., Pareek, V., Faiq, M. A., Ghosh, S. K., & Kumari, C. (2019) · PubMed · Cited by 110
Depression and lifestyle: Focusing on nutrition, exercise, and their possible relevance to molecular mechanisms
Kunugi, H. (2023) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13551 · Cited by 117
Endogenous H2S‑Activated Orthogonal Second Near-Infrared Emissive Nanoprobe for In Situ Ratiometric Fluorescence Imaging of Metformin-Induced Liver Injury
Deng, Z., Bi, S., Jiang, M., & Zeng, S. (2021) · ACS Nano · doi:10.1021/acsnano.0c09799 · Cited by 106
Alzheimer’s Disease and Inflammaging
Kosyreva, A., Sentyabreva, A., Tsvetkov, I., & Makarova, O. (2022) · Brain Sciences · doi:10.3390/brainsci12091237 · Cited by 98
Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?
Ala, M., & Ala, M. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00167 · Cited by 97
Berberine Ameliorates Diabetes-Associated Cognitive Decline through Modulation of Aberrant Inflammation Response and Insulin Signaling Pathway in DM Rats
Chen, Q., Mo, R., Wu, N., Zou, X., Shi, C., Gong, J., Li, J., Fang, K., Wang, D., De-shen, Y., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00334 · Cited by 92
Insulin Resistance is Associated with Depression Risk in Polycystic Ovary Syndrome
Greenwood, E. A., Pasch, L. A., Cedars, M. I., Legro, R. S., Eisenberg, E., & Huddleston, H. G. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.03.009 · Cited by 88
Drug Repositioning for Schizophrenia and Depression/Anxiety Disorders: A Machine Learning Approach Leveraging Expression Data
Zhao, K., & So, H. (2018) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2018.2856535 · Cited by 90
Mechanisms underpinning AMP-activated protein kinase-related effects on behavior and hippocampal neurogenesis in an animal model of depression
Odaira, T., Nakagawasai, O., Takahashi, K., Nemoto, W., Sakuma, W., Lin, J.-R., & Tan–No, K. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.026 · Cited by 80
Repositioning of diabetes treatments for depressive symptoms: A systematic review and meta-analysis of clinical trials
Moulton, C. D., Hopkins, C. W. P., Ismail, K., & Stahl, D. R. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.010 · Cited by 81
A biologically-informed polygenic score identifies endophenotypes and clinical conditions associated with the insulin receptor function on specific brain regions
Dass, S. A. H., McCracken, K., Pokhvisneva, I., Chen, L. M., Garg, E., Nguyen, T. T. T., Wang, Z., Barth, B., Yaqubi, M., McEwen, L. M., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.051 · Cited by 80
Cognitive dysfunction in major depression: From assessment to novel therapies
Atique-Ur-Rehman, H., & Neill, J. C. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.013 · Cited by 72
Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives
Salagre, E., Solé, B., Tomioka, Y., Fernandes, B. S., Hidalgo-Mazzei, D., Garriga, M., Jimenez, E., Sanchez-Moreno, J., Vieta, E., & Grande, I. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.034 · Cited by 71
Diabetes and Mental Health
Robinson, D. J., Hanson, K., Jain, A. B., Kichler, J. C., Mehta, G., Melamed, O. C., Vallis, M., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.04.009 · Cited by 73
Metformin and ascorbic acid combination therapy ameliorates type 2 diabetes mellitus and comorbid depression in rats
Shivavedi, N., Kumar, M., Tej, G. N. V. C., & Nayak, P. K. (2017) · Brain Research · doi:10.1016/j.brainres.2017.08.019 · Cited by 72
Neuromodulatory effects of anti-diabetes medications: A mechanistic review
Yaribeygi, H., Ashrafizadeh, M., Henney, N. C., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104611 · Cited by 71
Antidiabetes Agents and Incident Depression: A Nationwide Population-Based Study
Kessing, L. V., Rytgaard, H. C. W., Ekstrøm, C. T., Knop, F. K., Berk, M., & Gerds, T. A. (2020) · Diabetes Care · doi:10.2337/dc20-1561 · Cited by 70
Mitophagy in depression: Pathophysiology and treatment targets
Tripathi, A., Scaini, G., Barichello, T., Quevedo, J., & Pillai, A. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.08.016 · Cited by 71
Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field
Miskowiak, K. W., Ott, C. V., Petersen, J. Z., & Kessing, L. V. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.09.641 · Cited by 73
Metformin in elderly type 2 diabetes mellitus: dose-dependent dementia risk reduction
Sun, M., Chen, W., Wu, S., & Zhang, J. (2023) · Brain · doi:10.1093/brain/awad366 · Cited by 71
Metformin-induced anticancer activities: recent insights
Safe, S. H., Nair, V., & Karki, K. (2017) · Biological Chemistry · doi:10.1515/hsz-2017-0271 · Cited by 62
Metformin: A Prospective Alternative for the Treatment of Chronic Pain
Baeza‐Flores, G. D. C., Guzmán‐Priego, C. G., Flores, L. I. P., Murbartián, J., Torres‐López, J. E., & Granados‐Soto, V. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.558474 · Cited by 65
Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses
Possidente, C., Fanelli, G., Serretti, A., & Fabbri, C. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105298 · Cited by 63
Metformin Alters Locomotor and Cognitive Function and Brain Metabolism in Normoglycemic Mice
Li, W., Chaudhari, K., Shetty, R. A., Winters, A., Gao, X., Hu, Z., Ge, W., Sumien, N., Forster, M. J., Liu, R., et al. (2019) · Aging and Disease · doi:10.14336/ad.2019.0120 · Cited by 61
Type 2 Diabetes (T2DM) and Parkinson’s Disease (PD): a Mechanistic Approach
Sabari, S. S., Balasubramani, K., Iyer, M., Babu, H. W. S., Venkatesan, D., Gopalakrishnan, A. V., Narayanaswamy, A., Kumar, N. S., & Vellingiri, B. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03359-y · Cited by 64
Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones
(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.02.010 · Cited by 58
Metformin Improves the Depression Symptoms of Women with Polycystic Ovary Syndrome in a Lifestyle Modification Program
Alhussain, F. H., AlRuthia, Y. S., Al-Mandeel, H. M., Bellahwal, A., Alharbi, F., Almogbel, Y. S., Awwad, O., Dala'een, R., & Alharbi, F. A. (2020) · Patient Preference and Adherence · doi:10.2147/ppa.s244273 · Cited by 55
Anti-inflammatory medications for the treatment of mental disorders: A scoping review
Fitton, R., Sweetman, J., Heseltine-Carp, W., & van der Feltz-Cornelis, C. (2022) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2022.100518 · Cited by 53
Risk factors for depression in elderly diabetic patients and the effect of metformin on the condition
Chen, F., Wei, G., Wang, Y., Liu, T., Huang, T., Wei, Q., Ma, G., & Wang, D. (2019) · BMC Public Health · doi:10.1186/s12889-019-7392-y · Cited by 58
Leaky Gut Plays a Critical Role in the Pathophysiology of Autism in Mice by Activating the Lipopolysaccharide-Mediated Toll-Like Receptor 4–Myeloid Differentiation Factor 88–Nuclear Factor Kappa B Signaling Pathway
Li, F., Ke, H., Wang, S., Mao, W., Fu, C., Chen, X. X., Fu, Q., Qin, X., Huang, Y., Li, B., et al. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00993-9 · Cited by 61
Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders
Chen, Q., Cao, T., Li, N., Zeng, C., Zhang, S., Wu, X., Zhang, B., & Cai, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.667874 · Cited by 50
Metformin Administration During Early Postnatal Life Rescues Autistic-Like Behaviors in the BTBR T+ Itpr3tf/J Mouse Model of Autism
Wang, L. Y., Cai, Y., & Fan, X. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00290 · Cited by 48
Relationship between glycemic control and cognitive impairment: A systematic review and meta-analysis
Lin, Y., Gong, Z., Ma, C., Wang, Z., & Wang, K. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1126183 · Cited by 48
Impact of Insulin Sensitizers on the Incidence of Dementia: A Meta-Analysis
Ye, F., Luo, Y.-J., Xiao, J. F., Yu, N., & Yi, G. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000445941 · Cited by 47
Metformin improves cognitive impairment in patients with schizophrenia: associated with enhanced functional connectivity of dorsolateral prefrontal cortex
Shao, T., Huang, J., Zhao, Y., Wang, W., Tian, X., Hei, G., Kang, D., Gao, Y., Liu, F., Zhao, J., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02616-x · Cited by 45
Antidiabetic Drug Metformin Ameliorates Depressive-Like Behavior in Mice with Chronic Restraint Stress via Activation of AMP-Activated Protein Kinase
Ai, H., Fang, W., Hanyi, H., Xupang, H., & Lu, W. (2020) · Aging and Disease · doi:10.14336/ad.2019.0403 · Cited by 44
Impact of some oral hypoglycemic agents on type 2 diabetes-associated depression and reserpine-induced depression in rats: the role of brain oxidative stress and inflammation
Soliman, E., Essmat, N., Mahmoud, M. F., & Mahmoud, A. A. A. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01838-w · Cited by 45
The effect of metformin on cognitive function: A systematic review and meta-analysis
Tabatabaei‐Malazy, O., Bandarian, F., Qorbani, M., Mohseni, S., Mirsadeghi, S., Peimani, M., & Larijani, B. A. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211057304 · Cited by 43
Neurobiological findings underlying depressive behavior in Parkinson’s disease: A review
Mendonça, I. P., Duarte-Silva, E. P., Chaves-Filho, A. J. M., Andrade‐da‐Costa, B. L. D. S., & Peixoto, C. A. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106434 · Cited by 42
Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
Shoshan‐Barmatz, V., Anand, U., Crystal, E. N., Carlo, M. D., & Shteinfer‐Kuzmine, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.730048 · Cited by 42
Biomarkers for cognitive decline in patients with diabetes mellitus: evidence from clinical studies
Zhao, X. Y., Han, Q., Lv, Y., Sun, L., Gang, X., & Wang, G. (2017) · Oncotarget · doi:10.18632/oncotarget.23284 · Cited by 44
Metformin and cognition from the perspectives of sex, age, and disease
Chaudhari, K., Reynolds, C. D., & Yang, S.-H. (2020) · GeroScience · doi:10.1007/s11357-019-00146-3 · Cited by 43
Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression—A Literature Review
Woo, Y. S., Lim, H. K., Wang, S., & Bahk, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186969 · Cited by 43
The Effect of Metformin in Experimentally Induced Animal Models of Epileptic Seizure
Yimer, E. M., Surur, A., Wondafrash, D. Z., & Gebre, A. K. (2019) · Behavioural Neurology · doi:10.1155/2019/6234758 · Cited by 39
RETRACTED ARTICLE: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
Abdallah, M. S., Mosalam, E. M., Zidan, A. A., El-Attar, K. S., Zaki, S. A., Ramadan, A. N., & Ebeid, A. M. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00878-7 · Cited by 40
Retracted
Metformin monotherapy downregulates diabetes-associated inflammatory status and impacts on mortality
Tizazu, A. M., Nyunt, M. S. Z., Cexus, O., Suku, K., Mok, E., Xian, C. H., Chong, J., Tan, C., How, W., Hubert, S., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00572 · Cited by 37
Liver hydrolysate prevents depressive-like behavior in an animal model of colitis: Involvement of hippocampal neurogenesis via the AMPK/BDNF pathway
Nakagawasai, O., Yamada, K., Takahashi, K., Odaira, T., Sakuma, W., Ishizawa, D., Takahashi, N., Onuma, K., Hozumi, C., Nemoto, W., et al. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112640 · Cited by 37
Neuromodulatory effects of green coffee bean extract against brain damage in male albino rats with experimentally induced diabetes
Albrakati, A., Albarakati, A. J. A., Daabo, H. M. A., Baty, R. S., Salem, F. E. H., Habotta, O. A., Elmahallawy, E. K., Abdel-Mohsen, D. M., Taha, H., Akabawy, A. M. A., et al. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00583-6 · Cited by 37
A geroscience motivated approach to treat Alzheimer’s disease: Senolytics move to clinical trials
Gonzales, M. M., Krishnamurthy, S., Garbarino, V. R., Daeihagh, A. S., Gillispie, G. J., Deep, G., Craft, S., & Orr, M. E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111589 · Cited by 37
Novel targets for delaying aging: The importance of the liver and advances in drug delivery
Hunt, N. J., McCourt, P., Couteur, D. G. L., & Cogger, V. C. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.09.006 · Cited by 37
Insulin resistance: The role in comorbid type 2 diabetes mellitus and depression
Yao, J., Zhu, C., Sun, Y., Huang, Y., Li, Q., Liao, H.-M., Deng, X.-J., & Li, W.-M. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106218 · Cited by 45
Effect of canagliflozin and metformin on cortical neurotransmitters in a diabetic rat model
Arafa, N. M. S., Marie, M.-A. S., & AlAzimi, S. A. M. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.08.016 · Cited by 35
Neurocognitive correlates of metabolic dysregulation in individuals with mood disorders: a systematic review and meta-analysis
Maksyutynska, K., Stogios, N., Prasad, F., Gill, J., Hamza, Z., De, R., Smith, E., Horta, A., Goldstein, B. I., Korczak, D. J., et al. (2024) · Psychological Medicine · doi:10.1017/s0033291724000345 · Cited by 34
Metformin Exerts Antidepressant Effects by Regulated DNA Hydroxymethylation
Wang, Y., Liu, B., Yong, Y., Wang, Y., Zhao, Z., Miao, Z., & Zhu, J. (2019) · Epigenomics · doi:10.2217/epi-2018-0187 · Cited by 34
Metformin reprograms tryptophan metabolism via gut microbiome-derived bile acid metabolites to ameliorate depression-Like behaviors in mice
Xie, X., Li, W., Xiong, Z., Xu, J., Liao, T., Sun, L., Xu, H., Zhang, M., Zhou, J., Xiong, W., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.09.014 · Cited by 35
Self-citation
Promise of metformin for preventing age-related cognitive dysfunction
Shetty, A. K., Madhu, L. N., & Kodali, M. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.320971 · Cited by 34
Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence
Jones, B. D. M., Farooqui, S., Kloiber, S. M., Husain, M. O., Mulsant, B. H., & Husain, M. I. (2021) · Life · doi:10.3390/life11080819 · Cited by 35
The antidepressant-like activity of AC-5216, a ligand for 18KDa translocator protein (TSPO), in an animal model of diabetes mellitus
Qiu, Z.-K., He, J.-L., Liu, X., Zhang, G.-H., Zeng, J., Nie, H., Shen, Y., & Chen, J. (2016) · Scientific Reports · doi:10.1038/srep37345 · Cited by 34
Mechanisms of ageing: growth hormone, dietary restriction, and metformin
Khan, J., Pernicova, I., Nisar, K., & Korbonits, M. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00001-3 · Cited by 34
Age-Related Cognitive Decline and Dementia: Interface of Microbiome–Immune–Neuronal Interactions
Prajapati, S. K., Jain, S., & Yadav, H. (2025) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaf038 · Cited by 37
Metformin Ameliorates Lipopolysaccharide-Induced Depressive-Like Behaviors and Abnormal Glutamatergic Transmission
Jiang, C., Zhou, T. G., Chen, W., Lin, D., Guo, A., Liu, Z., & Fei, E. (2020) · Biology · doi:10.3390/biology9110359 · Cited by 33
An association between multi-morbidity and depressive symptoms among Indian adults based on propensity score matching
Singh, S. K., Shri, N., & Dwivedi, L. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-18525-w · Cited by 31
The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression
Battini, V., Cirnigliaro, G., Leuzzi, R., Rissotto, E., Mosini, G., Benatti, B., Pozzi, M., Nobile, M., Radice, S., Carnovale, C., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1215807 · Cited by 29
Metformin alleviates monoamine oxidase-related vascular oxidative stress and endothelial dysfunction in rats with diet-induced obesity
Ionică, L. N., Gaiţă, L., Bînă, A. M., Șoșdean, R., Lighezan, R., Sima, A. C., Malita, D. C., Cretu, O. M., Burlacu, O. N., Muntean, D. M., et al. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04194-2 · Cited by 30
Agmatine as a novel candidate for rapid-onset antidepressant response
Valverde, A. P., Camargo, A., & Rodrigues, A. L. S. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i11.981 · Cited by 31
A Clinical Perspective of the Multifaceted Mechanism of Metformin in Diabetes, Infections, Cognitive Dysfunction, and Cancer
Chow, E., Yang, A., Chung, C. H. L., & Chan, J. C. N. (2022) · Pharmaceuticals · doi:10.3390/ph15040442 · Cited by 30
Metformin: Repurposing Opportunities for Cognitive and Mood Dysfunction
Ying, M., Maruschak, N., Mansur, R., Carvalho, A., Cha, D., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130205514 · Cited by 29
Drug Repurposing for the Management of Depression: Where Do We Stand Currently?
Sadeghi, H. M., Adeli, I., Mousavi, T., Daniali, M., Nikfar, S., & Abdollahi, M. R. (2021) · Life · doi:10.3390/life11080774 · Cited by 29
Crosstalk of metabolic factors and neurogenic signaling in adult neurogenesis: Implication of metabolic regulation for mental and neurological diseases
Gao, C., Wang, Q., Chung, S. K., & Shen, J. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.02.001 · Cited by 28
The association between insulin resistance, metabolic variables, and depressive symptoms in Mexican‐American elderly: A population‐based study
Diniz, B. S., Fisher‐Hoch, S. P., & McCormick, J. B. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4792 · Cited by 29
Hippocampal and gut AMPK activation attenuates enterocolitis-like symptoms and co-occurring depressive-like behavior in ulcerative colitis model mice: Involvement of brain-gut autophagy
Takahashi, K., Kurokawa, K., Hong, L., Miyagawa, K., Mochida-Saito, A., Takeda, H., & Tsuji, M. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114671 · Cited by 28
Exercise as a Moderator of Persistent Neuroendocrine Symptoms of COVID-19
Rebello, C. J., Axelrod, C. L., Reynolds, C. F., Greenway, F. L., & Kirwan, J. P. (2022) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000284 · Cited by 29
Nutrition, anxiety and hormones. Why sex differences matter in the link between obesity and behavior.
Clark, T. D., Reichelt, A. C., Ghosh‐Swaby, O. R., Simpson, S. J., & Crean, A. J. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.113713 · Cited by 27
Metformin: A Growing Journey from Glycemic Control to the Treatment of Alzheimer’s Disease and Depression
El Massry, M., Alaeddine, L. M., Ali, L., Saad, C., & Eid, A. A. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867327666200908114902 · Cited by 27
Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation
Markowicz-Piasecka, M., Huttunen, K. M., & Sikora, J. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1499627 · Cited by 27
Targeting Myotonic Dystrophy Type 1 with Metformin
García-Puga, M., Saenz‐Antoñanzas, A., Matheu, A., & de Munaín, A. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052901 · Cited by 26
Cognitive impairment in patients with type 2 diabetes mellitus: prevalence, pathogenetic mechanisms, the effect of antidiabetic drugs
Ostroumova, O. D., Surkova, E. V., Chikh, E. V., Rebrova, E. V., & Borisov, M. S. (2018) · Diabetes Mellitus · doi:10.14341/dm9660 · Cited by 29

Authors: Guo, M., Mi, J., Jiang, Q., Xu, J., Tang, Y., Tian, G., & Wang, B.
Affiliations: Harbin Medical University (CN)
Binzhou Medical University (CN)
Division of Endocrinology Aerospace Center Hospital Aerospace Clinical Medical College Peking University Beijing China
Department of Endocrinology Fourth Affiliated Hospital of Harbin Medical University Harbin China
Corresponding author: Guo, Min
ORCID: Guo, Min
Mi, Jia
Tian, Geng
Wang, Bin
Venue: Clinical and Experimental Pharmacology and Physiology
Publisher: Wiley
Published: 2014-09
Volume: 41
Issue: 9
Pages: 650-656
ISSN: 0305-1870 (ISSN-L)
1440-1681
DOI: 10.1111/1440-1681.12265
OpenAlex: W2069494503
Cited by: 225
References: 46
Citations by year: 2026: 7 · 2025: 16 · 2024: 9 · 2023: 27 · 2022: 30 · 2021: 28 · 2020: 34 · 2019: 21 · 2018: 22 · 2017: 17 · 2016: 8 · 2015: 6
FWCI: 7.58
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 55 d)
Locations: Clinical and Experimental Pharmacology and Physiology (publishedVersion)
PubMed (publishedVersion)
Funders: Peking University
Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: metformin, antidepressant effects, depression, type 2 diabetes, cognitive impairment, cognitive function, glucose metabolism, depressive symptoms, comorbidities, antidiabetic drugs
MeSH terms: Adult, Antidepressive Agents, Cognition, Depression, Diabetes Mellitus, Type 2, Double-Blind Method, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Psychiatric Status Rating Scales, Wechsler Scales

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks